¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sleep restriction therapy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® sleep ÇÑ±Û Àá, ¼ö¸é
¼³¸í   
  ÀÇÁöÀÛ¿ë ¹× ÀǽÄÀÌ ºÎºÐÀûÀ¸·Î ¶Ç´Â ¿ÏÀüÈ÷ Á¤ÁöµÇ°í ½ÅüÀû ±â´ÉÀÌ ºÎºÐÀûÀ¸·Î Á¤ÁöµÇ´Â ¸ö°ú ¸¶À½ÀÇ »óÅÂ. ¼ö¸éÀº ÀÔ¸é±â, °¡º­¿î ¼ö¸é±â, ±íÀº ¼ö¸é±â, ·½¼ö¸é±âÀÇ 4»óÀ¸·Î ³ª´µ¾î ÀÖ´Ù. ±íÀº ¼ö¸é¿¡¼­ ·½¼ö¸é±îÁöÀÇ Áֱ⸦ ¼ö¸éÁÖ±â¶ó°í Çϸ砾à 90ºÐÀÇ ÁÖ±â·Î ÇÏ·ç¿¡ 4~5ȸ µÇÇ®À̵ȴÙ. ¼ö¸éÀÇ ÁÖ±â´Â ³ú³»ÀÇ ¼ö¸éÀ» ÀÏÀ¸Å°´Â ±â±¸¿Í °¢¼ºÀ» ÀÏÀ¸Å°´Â ±â±¸°¡ ¹ø°¥¾Æ ÀÛµ¿Çؼ­ Çü¼ºµÇ°í ÀÖ´Ù. ¾ÆÄ§¿¡ ´«À» ¶°¼­ ¹ã¿¡ Àáµç´Ù´Â ±âº»ÀûÀΠÀÏÁֱ⠸®µëÀº ½Ã»óÇϺÎÀÇ ½Ã°¢±³Â÷À§ÇÙ¿¡ ÀÇÇØ¼­ ¾ïÁ¦µÇ°í ÀÖ´Ù. ¼ö¸é½Ã°£Àº ½Å»ý¾Æ¿¡¼­ ¾à 15½Ã°£ÀÌ ³ª ÀÖÀ¸³ª ¼ºÀο¡¼­ ¾à 8½Ã°£, ³ëÀÎÀÌ µÇ¸é ¾à 6½Ã°£ Á¤µµÀÌ´Ù. ·½¼ö¸éÀº ½Å»ý¾Æ¿¡¼­ ¾à 8½Ã°£À̳ª µÇÁö¸¸ Ãâ»ý ÈÄ 2³â°ºÎÅÍ ±Þ°ÝÈ÷ °¨¼ÒÇÑ´Ù. ¼ö¸é·®Àº »ýÁã µîÀÇ »ê¼Ò¼Òºñ·®ÀÌ ¸¹Àº µ¿¹°Àϼö·Ï ±æ°í ÄÚ³¢¸®¿Í °°Àº ÀûÀº µ¿¹°Àϼö·Ï Âª´Ù. ¼ö¸éÀº ¿¡³ÊÁö¼Òºñ·®ÀÇ ÀúÇϳª Á¤»óÁ¤½Å»óÅÂÀÇ À¯Áö¿¡µµ °ü¿©ÇÑ´Ù°í »ý°¢µÇ°í ÀÖ´Ù. 
  
  
¿µ¹® family therapy ÇÑ±Û °¡Á·¿ä¹ý
¼³¸í   
  °¡Á·À» Ä¡·á ´ë»óÀ¸·Î Çϴ ½É¸®¿ä¹ý ÁßÀÇ Çϳª. °¡Á·ÁßÀÇ ¹®Á¦´Â ¹®Á¦¸¦ °¡Áø °³Àθ¸ÀÌ ¾Æ´Ï¶ó ¹®Á¦ °¡Á·À» ´ë»óÀ¸·Î ÇذáÇØ ³ª°¥ Çʿ䰡 Àִٴ ÀνÄÀ» ¹ÙÅÁÀ¸·Î ÇÏ¿© °¡Á· ÀüüÀÇ ½É¸®Àû ¼º¼÷À» ¸ñÇ¥·Î ÇÑ ¿ä¹ýÀÌ´Ù. Å©°Ô ³ª´©¾î °¡Á· ÁßÀǠƯÁ¤ÀÎÀ» ´ë»óÀ¸·Î ÇÏ¿© °¢°¢ ´Ù¸¥ µ¶¸³µÈ Ä¡·á¸¦ Çϴ º´Çà½É¸®¿ä¹ý°ú °¡Á· Àüü¸¦ µ¿½Ã ¸éÁ¢Çϴ ¹æ¹ýÀ» ÁַΠÇϴ ÇÕµ¿°¡Á·¿ä¹ýÀÌ Àִµ¥, Æ¯È÷ ÈÄÀÚ¸¦ °¡¸®ÄÑ °¡Á·¿ä¹ý À̶ó°í Çϴ °æ¿ì°¡ ¸¹´Ù.
¿µ¹® intracavitary therapy ÇÑ±Û °­³»¿ä¹ý
¼³¸í   
  Ã¼°­³», Áï ÀÔ¾È, ÄÚ¾È, Àεΰ­, ½Äµµ, °ðâÀÚ, Áú, Àڱøñ, ¹æ±¤ µîÀÇ ³»°­¿¡, ¶§·Î´Â º´ÅÍ¿¡ ÀÇÇØ »ý±ä °øµ¿³»¿¡ ¹æ»ç¼±À» »ðÀÔÇØ¼­ Ä¡·áÇϴ °ÍÀ» ¸»ÇÑ´Ù. ÁַΠÁ¾¾çÀÇ Ä¡·á¸¦ ¸ñÀûÀ¸·Î ÇÑ´Ù.
¿µ¹® hyperbaric oxygenation therapy ÇÑ±Û °í¾Ð»ê¼Ò¿ä¹ý
¼³¸í   
  ´ë±â¾Ðº¸´Ù ³ôÀº ±â¾Ðȯ°æÀ» ÀΰøÀûÀ¸·Î ¸¸µé¾î ±× ¾È¿¡¼­ °í³óµµÀÇ »ê¼Ò¸¦ ÈíÀÔ½Ã۴ ¿ä¹ý. Çѱ¹¿¡¼­ ¿¬Åº°¡½º·Î ´ëÇ¥µÇ´Â ÀÏ»êȭź¼ÒÀÇ ±Þ¼ºÁßµ¶ÀÇ Ä¡·á¿¡ ¸¹ÀÌ ÀÌ¿ëµÈ °ÍÀ¸·Î, º¸Åë 3´ë±â¾Ð Á¤µµ·Î °¡¾ÐµÈ °í¾Ð»ê¼Ò½ÇÀ̳ª °í¾Ð»ê¼ÒÅÊÅ© ¼Ó¿¡ È¯ÀÚ¸¦ ³õ°í Àü½Å¿¡ »ê¼Ò¸¦ ÈíÀÔ½ÃŲ´Ù. °í¾Ð½ÇÀº Å©°í ÀÛÀº ¿©·¯ °¡Áö°¡ ÀÖÀ¸¸ç, ±¸Á¶»ó 1½Ç½Ä-2½Ç½Ä-´Ù½Ç½ÄÀÌ ÀÖ´Ù. °¡¾Ð °¡½ºÀÇ Á¾·ù¿¡´Â »ê¼Ò-°ø±â-È¥ÇÕ °¡½ºµîÀÌ ÀÖ°í, 2~3 ´ë±â¾Ð ¶Ç´Â ±× ÀÌ»óÀÇ °í¾Ð È¯°æÀ» ¸¸µç´Ù. ÀÓ»óÀûÀ¸·Î ÀÀ¿ë¹üÀ§°¡ ³Ð¾î¼­ ±â°èÀû È¿°ú¿¡ ÀÇÇÏ¿© Àá¼öºÎº´À̳ª Ã¢ÀÚ°ü¸¶ºñ¿¡ ÀÇÇѠâÀÚÆó»ö Ä¡·á µî¿¡ À¯È¿Çϰí, °¡½º±ËÀú µîÀÇ ¹«»ê¼Ò¼º ¼¼±Õ°¨¿°¿¡¼­µµ ÀÌ¿ëµÈ´Ù. ¶Ç »ê¼Ò¿î¹ÝÈ¿°ú¿¡ ÀÇÇÏ¿© ÀÏ»êȭź¼Ò-½É±Ù°æ»ö-³ú»öÀüÁõ-ÃâÇ÷¼îÅ©¿¡ ÀÇÇÑ ±Þ¼ºÀÇ Á¶Á÷»ê¼Ò°áÇÌÀÇ Ä¡·á¿¡ À¯È¿ÇÏ´Ù. ¶Ç ¾ÏÀÇ ¹æ»ç¼±¿ä¹ý¿¡ º´¿ëÇϸé ÀÌ ¿ä¹ýÀ¸·Î ¾Ï¼¼Æ÷ÀÇ ºÐ¿­ÀÌ ¿Õ¼ºÇØÁ®, ¼¼Æ÷ºÐ¿­ ÁßÀΠ¼¼Æ÷¿¡ ¹æ»ç¼±À» Á¶»çÇÔÀ¸·Î½á ºÐ¿­´É·ÂÀ» ¾ø¾Ö´Â µ¥ À¯È¿ÇÏ¿© °í¾Ð»ê¼ÒÈíÀÔÁ¶»ç¹ýÀ̶ó°í ÇÑ´Ù.
¿µ¹® interstitial therapy ÇÑ±Û ±ÙÁ¢Ä¡·á
¼³¸í   
  ÁַΠÁ¾¾çÀÇ Ä¡·á¸¦ ¸ñÀûÀ¸·Î ÇÏ¿© ÀÎü Á¶Á÷³»¿¡ ¹æ»ç¼± ¹°ÁúÀ» »ðÀÔÇÏ¿© ¹æ»ç¼±À» Á¶»çÇϴ ġ·á¹ýÀÌ´Ù. Brachytherapy¶ó°íµµ ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • asymmetric fetal growth restriction
    ºñ´ëĪžƼºÀåÁ¦ÇÑ
  • genetic restriction
    À¯Àü»óÈ£ÀÛ¿ëÁ¦ÇÑ
  • intrauterine growth restriction
    Àڱ󻼺ÀåÁ¦ÇÑ
  • restriction
    Á¦ÇÑ
  • restriction endonuclease
    Á¦ÇÑÇÙ¼ÓÇÙ»êºÐÇØÈ¿¼Ò, Á¦ÇÑ¿£µµ´ºÅ¬·¹¾ÆÁ¦
  • restriction enzyme
    Á¦ÇÑÈ¿¼Ò
  • restriction fragment length polymorphism
    Á¦ÇÑÀýÆí±æÀÌ´ÙÇüÅÂ
  • restriction map
    Á¦ÇÑÈ¿¼ÒÁöµµ
  • advanced sleep phase syndrome
    ÀüÁø¼ö¸éÀ§»óÁõÈıº
  • breathing related sleep disorder
    È£Èí°ü·Ã¼ö¸éÀå¾Ö
  • circadian rhythm sleep disorder
    ÇÏ·çÁÖ±âÀ²µ¿¼ö¸éÀå¾Ö, ÀÏÁÖ±âÀ²µ¿¼ö¸éÀå¾Ö
  • central sleep apnea
    ÁßÃß¼ö¸é¹«È£Èí
  • delayed sleep phase
    ¼ö¸éÀ§»óÁö¿¬
  • delayed sleep phase syndrome
    ¼ö¸éÀ§»óÁö¿¬ÁõÈıº
  • delta sleep
    µ¨Å¸¼ö¸é
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • restriction enzyme
    Á¦ÇÑÈ¿¼Ò
  • restriction map
    Á¦ÇÑÈ¿¼ÒÁöµµ
  • restriction
    Á¦ÇÑ
  • intrauterine growth restriction
    Àڱ󻼺ÀåÁö¿¬
  • salt restriction
    ¿°ºÐÁ¦ÇÑ
  • water restriction
    ¹°Á¦ÇÑ, ¼öºÐÁ¦ÇÑ
  • sleep apnea
    ¼ö¸é¹«È£Èí
  • sleep bruxism
    À̰¥±â
  • sleep habit
    Àá¹ö¸©, ¼ö¸é½À°ü
  • sleep hygiene
    ¼ö¸éÀ§»ý
  • sleep latency
    ¼ö¸éÀẹ±â
  • sleep
    Àá, ¼ö¸é
  • sleep spindle
    ¼ö¸é¹æÃß
  • sleep seizure
    ¼ö¸é¹ßÀÛ
  • therapy
    ¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sleep position restriction
    ¼ö¸éÀÚ¼¼Á¦ÇÑ
  • prolonged sleep therapy
    ¼ö¸é¿¬ÀåÄ¡·á
  • restriction endonuclease
    Á¦ÇÑÀûÇÙ¼ÓÇÙ»êºÐÇØÈ¿¼Ò, Á¦ÇÑÀû¿£µµ´ºÅ¬·¹¾ÆÁ¦
  • restriction enzyme
    Á¦ÇÑÈ¿¼Ò
  • genetic restriction
    À¯ÀüÀû»óÈ£ÀÛ¿ëÁ¦ÇÑ
  • haplotype restriction
    ÀϹè¼öüÁ¦ÇÑ
  • restriction map
    Á¦ÇÑÈ¿¼ÒÁöµµ
  • restriction fragment length polymorphism
    Á¦ÇÑÀýÆí±æÀÌ´ÙÇü¼º
  • restriction
    Á¦ÇÑ
  • restriction endonuclease
    Á¦ÇÑÇٻ곻ºÎ°¡¼öºÐÇØÈ¿¼Ò
  • advanced sleep phase syndrome
    ÀüÁø¼ö¸éÀ§»óÁõÈıº
  • obstructive sleep apnea
    Æó¼â¼ö¸é¹«È£Èí
  • REM sleep promoting area
    ·½¼ö¸éÃËÁø¿µ¿ª
  • sleep activation
    ¼ö¸éȰ¼º
  • sleep apnea
    ¼ö¸é¹«È£Èí
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • prolonged sleep therapy
    Áö¼Ó¼ö¸é¿ä¹ý, Àå±â¼ö¸é¿ä¹ý(íåÑ¢â²ØùèþÛö).
  • Ia restriction
    IaÂ÷À̼ö¹Ý ¸é¿ª»óÈ£ÀÛ¿ëÁ¦ÇÑ
  • haplotype restriction
    ÁÖÁ¶Á÷ÀûÇÕÇ׿øº¹ÇÕü¿°»öü Â÷À̼ö¹Ý ¸é¿ªÁ¦ÇÑ
  • homologous restriction factor
    µ¿Á¾Á¦ÇÑÀÎÀÚ
  • OSAS=obstructive sleep apnea syndrome
    Æó¼â¼º ¼ö¸é ¹«È£Èí ÁõÈıº
  • PLMS.see periodic limb movements during sleep
    ¼ö¸éÁß ÁÖ±âÀû »çÁö¿îµ¿
  • REM sleep behavior disorder
    ·½¼ö¸éÇൿÀå¾Ö(º´)
  • REM-sleep-promoting area
    ·½¼ö¸éÁõÁø¿µ¿ª
  • REM-sleep-related sinus arrest
    ·½¼ö¸é °ü·Ã ½ÉÀ嵿°áÀý(Ô×Ì¿ï½) Á¤Áö
  • adjustment sleep disorder
    ÀûÀÀ¼º ¼ö¸éÀå¾Ö(º´), ¼ö¸é Á¶Á¤ Àå¾Ö(º´)
  • advanced sleep phase syndrome
    ÀüÁø¼º ¼ö¸éÀ§»ó ÁõÈıº
  • hibernation =winter sleep
    µ¿¸é(ËÄËÎ), ¿ùµ¿(ËôËÄ), µ¿¸é¸¶Ãë, Àúü¿Â¹ý (ËøÌ§ËíËÑ).
  • hypnobatia =sleep walking
    ¸ùÀ¯(Áõ)(ÙÓë´ñø)
  • induced sleep
    À¯µµ¼ö¸é(¡­â²Øù).
  • induced sleep
    À¯µµ¼ö¸é(ë¯Óôâ²Øù)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sleep restriction therapy
    ¼ö¸éÁ¦ÇÑ¿ä¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sleep position restriction
    ¼ö¸éÀÚ¼¼Á¦ÇÑ
  • orthodox sleep =NREM sleep
    Á¤¼ö¸é(ïáâ²Øù), ³í·½¼ö¸é, ¿©ÆÄ¼ö¸é(æ®÷î â²Øù).
  • paradoxical sleep,see REM sleep
    ¿ª¼³Àû ¼ö¸é, ·½ ¼ö¸é
  • prolonged sleep therapy
    Áö¼Ó¼ö¸é¿ä¹ý, Àå±â¼ö¸é¿ä¹ý(íåÑ¢â²ØùèþÛö).
  • endonuclease, restriction
    Á¦ÇÑÈ¿¼Ò
  • enzyme, restriction
    Á¦ÇÑÈ¿¼Ò
  • haplotype restriction
    ÁÖÁ¶Á÷ÀûÇÕÇ׿øº¹ÇÕü¿°»öü Â÷À̼ö¹Ý ¸é¿ªÁ¦ÇÑ
  • homologous restriction factor
    µ¿Á¾Á¦ÇÑÀÎÀÚ
  • legal restriction
    ¹ýÀûÇѰè(¡­ùÚÍ£).
  • legal restriction
    ¹ýÀûÇѰè(ÊṴ̀˭).
  • mst ii restriction enzyme
    Mst II Á¦ÇÑÈ¿¼Ò(¡­ ð¤ùÚý£áÈ)
  • restriction analysis
  • restriction endonuclease
    Á¦ÇÑ¿£µµ´ºÅ¬¸®¿¡ÀÌÁî
  • restriction endonuclease
    Á¦ÇÑÈ¿¼Ò
  • restriction endonucleases
    Á¦ÇÑÇÙ»ê ³»ºÎ°¡¼öºÐÇØÈ¿¼Ò
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • malarial therapy
    ¸»¶ó¸®¾Æ¿ä¹ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antidotal therapy
    Ç×ÇØµ¶Ä¡·á(ù÷ú°Ô¸ö½Öû)
  • enzyme replacement therapy
    È¿¼Ò ´ëü Ä¡·á (ý£áÈÓÛôðö½Öû)
  • enzyme therapy
    È¿¼ÒÄ¡·á (ý£áÈö½Öû)
  • gene therapy
    À¯ÀüÀÚ Ä¡·á(ë¶îîí­ö½Öû)
  • DNA restriction enzyme
    DNA Á¦ÇÑ È¿¼Ò(ð¤ùÚý£áÈ) (ÔÒ) restriction enzyme
  • host-controlled restriction
    ¼÷ÁÖÁ¦¾î Á¦ÇÑ(âÖñ«ð¤åÙð¤ùÚ)
  • modification and restriction
    ¼ö½Ä(áóãÞ)°ú Á¦ÇÑ(ð¤ùÚ)
  • restriction
    Á¦ÇÑ(ð¤ùÚ)
  • restriction allele
    Á¦ÇÑ ´ë¸³À¯ÀüÀÚ(Óߨ¡ë¶îîí­)
  • restriction endonuclease
    Á¦ÇÑ ¿£µµ´ºÅ¬¸®¿¡À̽º
  • restriction enzyme
    Á¦ÇÑÈ¿¼Ò(ð¤ùÚý£áÈ)
  • restriction fragment
    Á¦ÇÑ Á¶°¢
  • restriction fragment length polymorphism
    Á¦ÇÑ Á¶°¢±æÀÌ ´ÙÇü¼º(Òýúþàõ)
  • restriction gene
    Á¦ÇÑ À¯ÀüÀÚ(ë¶îîí­)
  • restriction map
    Á¦ÇÑ Áöµµ(ò¢Óñ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • restriction
    ÇÑ, Á¦ÇÑ
  • adjuvant therapy
    º¸Á¶¿ä¹ý
  • isotope therapy
    µ¿À§¿ø¼ÒÄ¡·á
  • maintenance therapy
    À¯Áö¿ë¹ý
  • percutaneous ethanol injection therapy
    °æÇÇÀû¿¡Å¸³îÁÖÀÔ¿ä¹ý
  • radiation therapy
    ¹æ»ç¼±Ä¡·á
  • radium therapy
    ¶óµãÄ¡·á
  • replacement therapy
    º¸»ó¿ä¹ý, ´ëÄ¡¿ä¹ý
  • therapy
    Ä¡·á, ¿ä¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CT calcitonin; calf testis; cardiac tamponade; cardiothoracic [ratio]; carotid tracing; carpal tunnel; ...
IT immunological test; immunotherapy; implantation test; individual therapy; information technology; in...
MT magnetization transfer; malaria therapy; malignant teratoma; mammary tumor; mammilothalamic tract; m...
GT gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm...
RT radiologic technologist; radiotelemetry; radiotherapy; radium therapy; rapid tranquilization; reacti...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ARDRA Amplified ribosomal DNA restriction analysis
CR Caloric restriction
DR Diet restriction
DR Dietary restriction
ER Energy restriction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • extracapsular restriction
    °üÀý³¶¿Ü Á¦ÇÑ, °üÀý³¶¿Ü °³±¸ Á¦ÇÑ
  • restriction
    °³±¸ Á¦ÇÑ, Á¦ÇÑ
  • adjustment sleep disorder
    ÀûÀÀ¼º ¼ö¸éÀå¾Ö, ÀûÀÀ¼º ¼ö¸éÀå¾Ö º´, ¼ö¸é Á¶Á¤ Àå¾Ö, ¼ö¸é Á¶Á¤ Àå¾Ö º´
  • delta sleep
    µ¨Å¸ ¼ö¸é
    ½Å¼Ó ¾È±¸ ¿îµ¿ÀÌ ÀϾÁö ¾Ê´Â Á¦4±âÀÇ ±íÀº ¼ö¸é.
  • interruption of sleep
    ¼ö¸é Àå¾Ö
  • natural sleep
    ÀÚ¿¬ ¼ö¸é
  • nonrestorative sleep syndrome
    ȸº¹ ºÒ´É¼º ¼ö¸é ÁõÈıº
  • obstructive sleep apnea
    Æó¼â¼º ¹«È£Èí
  • paradoxical sleep
    ¿ª¼³ ¼ö¸é
  • paroxysmal sleep
    ¹ßÀÛ¼º ¼ö¸é
  • poor quality of sleep
    ¼ö¸é ºÒ·®
  • rapid eye movement sleep
    ½Å¼Ó ¾È±¸¿îµ¿ ¼ö¸é, REM ¼ö¸é
    ½É¹Úµ¿, È£Èí ¼ö, Ç÷¾ÐÀÇ ½ÉÇÑ Áõ°¡, ±×¸®°í ºü¸¥ ¾È±¸ ¿îµ¿ ±â°£, ±Ù¿¬Ãà
  • sleep apnea
    ¼ö¸é ¹«È£ÈíÁõ, ¼ö¸é ¹«È£Èí
    ¼ö¸é Áß¿¡ ÀϾ´Â È£Èí ÀÌ»óÀ¸·Î¼­ È£Èí ´É·üÀÇ ºÎÁ·À¸·Î ÀÌÂ÷ÀûÀ¸·Î °ø±âÀÇ È帧ÀÌ ÁߴܵǴ °ÍÀÌ Æ¯Â¡ÀÌ´Ù. º¸Åë »ó±âµµ Æó¼â¿Í °ü·ÃµÇÁö¸¸ ÁßÃß¼º ¿øÀΰú °ü·ÃµÉ ¼ö ÀÖ´Ù.
  • sleep assessment
    ¼ö¸é Æò°¡
  • sleep deprivation
    ¼ö¸é ¹ÚÅ»
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
electrotherapeutic sleep therapy Treatment by inducing sleep by means of nonconvulsive electric stimulation of the brain.
(05 Mar 2000)
cell cycle restriction point <cell biology, molecular biology> A point, late in G1, after which the cell must, normally, proceed through to division at its standard rate.
(26 Mar 1998)
restriction 1. The process with which foreign DNA that has been introduced into a prokaryotic cell becomes ineffective.
2. A limitation.
(05 Mar 2000)
restriction endonuclease <enzyme, molecular biology> Class of bacterial enzymes that cut DNA at specific sites. In bacteria their function is to destroy foreign DNA, such as that of bacteriophages (host DNA is specifically modified at these sites).
Type I restriction endonucleases occur as a complex with the methylase and a polypeptide that binds to the recognition site on DNA. They are often not very specific and cut at a remote site.
Type II restriction endonucleases are the classic experimental tools. They have very specific recognition and cutting sites. The recognition sites are short, 4-8 nucleotides and are usually palindromic sequences. Because both strands have the same sequence running in opposite directions the enzymes make double stranded breaks, which, if the site of cleavage is off centre, generates fragments with short single stranded tails, these can hybridise to the tails of other fragments and are called sticky ends.
They are generally named according to the bacterium from which they were isolated (first letter of genus name and the first two letters of the specific name). The bacterial strain is identified next and multiple enzymes are given Roman numerals. For example the two enzymes isolated from the R strain of E. Coli are designated Eco RI and Eco RII.
(10 Mar 1998)
restriction enzyme <enzyme, molecular biology> Class of bacterial enzymes that cut DNA at specific sites. In bacteria their function is to destroy foreign DNA, such as that of bacteriophages (host DNA is specifically modified at these sites).
Type I restriction endonucleases occur as a complex with the methylase and a polypeptide that binds to the recognition site on DNA. They are often not very specific and cut at a remote site.
Type II restriction endonucleases are the classic experimental tools. They have very specific recognition and cutting sites. The recognition sites are short, 4-8 nucleotides and are usually palindromic sequences. Because both strands have the same sequence running in opposite directions the enzymes make double stranded breaks, which, if the site of cleavage is off centre, generates fragments with short single stranded tails, these can hybridise to the tails of other fragments and are called sticky ends.
They are generally named according to the bacterium from which they were isolated (first letter of genus name and the first two letters of the specific name). The bacterial strain is identified next and multiple enzymes are given Roman numerals. For example the two enzymes isolated from the R strain of E. Coli are designated Eco RI and Eco RII.
(10 Mar 1998)
restriction enzyme cutting site <molecular biology> A specific nucleotide sequence of DNA at which a particular restriction enzyme cuts the DNA.
Some sites occur frequently in DNA (for example, every several hundred basepairs), others much less frequently (rare-cutter, for example, every 10,000 base pairs).
(10 Mar 1998)
restriction enzyme, endonuclease A protein that recognises specific, short nucleotide sequences and cuts DNA at those sites. Bacteria contain over 400 such enzymes that recognise and cut over 100 different DNA sequences. See restriction enzyme cutting site.
(05 Mar 2000)
restriction fragment <molecular biology> The fragments of DNA generated by digesting DNA with a specific restriction endonuclease. Each of the fragments ends in a site recognised by that specific enzyme.
(10 Mar 1998)
restriction fragment length polymorphism <molecular biology, technique> A method that allows familial relationships to be established by comparing the characteristic polymorphic patterns that are obtained when certain regions of genomic DNA are amplified (typically by PCR) and cut with certain restriction enzymes.
The variation in the length of DNA fragments produced by a restriction endonuclease that cuts at a polymorphic locus. Such variations are generated by mutations that create or abolish recognition sites for these enzymes.
This is a key tool in DNA fingerprinting, reflecting the existence of different alleles in the individual. Restriction fragment length polymorphism mapping is also used in plant breeding to see if a key trait such as disease resistance is inherited.
In principle, an individual can be identified unambiquously by restriction fragment length polymorphism hence the use of restriction fragment length polymorphism in forensic analysis of blood, hair or semen).
Similarly, if a polymorphism can be identified close to the locus of a genetic defect, it provides a valuable marker for tracing the inheritance of the defect.
Synonym: DNA fingerprinting.
Acronym: RFLP
(12 Jan 1998)
restriction length polymorphism Fragment length polymorphism, the existence of allelic forms recognizable by the length of fragments that result when the nucleotide chain is treated by a specific restriction enzyme that cleaves wherever a particular sequence of nucleotides occurs. A mutation in this sequence changes cleaving and hence the number of fragments.
(05 Mar 2000)
restriction map <molecular biology> Map of DNA showing the position of sites recognised and cut by various restriction endonucleases.
(12 Jan 1998)
restriction mapping Use of restriction endonucleases to analyze and generate a physical map of genomes or genes. The nucleotide sequence determined is often then translated into an amino acid sequence, providing a means for sequencing the protein for which the gene codes, or for which the mRNA is a messenger.
(12 Dec 1998)
restriction methylation The enzymatic addition of methyl groups to selected adenine and cytosine residues to protect from hydrolysis by certain restriction enzymes.
(05 Mar 2000)
restriction nuclease <enzyme, molecular biology> Class of bacterial enzymes that cut DNA at specific sites. In bacteria their function is to destroy foreign DNA, such as that of bacteriophages (host DNA is specifically modified at these sites).
Type I restriction endonucleases occur as a complex with the methylase and a polypeptide that binds to the recognition site on DNA. They are often not very specific and cut at a remote site.
Type II restriction endonucleases are the classic experimental tools. They have very specific recognition and cutting sites. The recognition sites are short, 4-8 nucleotides and are usually palindromic sequences. Because both strands have the same sequence running in opposite directions the enzymes make double stranded breaks, which, if the site of cleavage is off centre, generates fragments with short single stranded tails, these can hybridise to the tails of other fragments and are called sticky ends.
They are generally named according to the bacterium from which they were isolated (first letter of genus name and the first two letters of the specific name). The bacterial strain is identified next and multiple enzymes are given Roman numerals. For example the two enzymes isolated from the R strain of E. Coli are designated Eco RI and Eco RII.
(10 Mar 1998)
restriction site A sequence in DNA that can be recognised and cut by a specific restriction enzyme.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • restriction
    Á¦ÇÑ
  • import restriction
    ¼öÀÔÁ¦ÇÑ(±ÔÁ¦)
  • restriction
    Á¦ÇÑ;ÇÑÁ¤;±¸¼Ó;¼Ó¹Ú;Á¦ÇÑ(Á¦¾à)ÇÏ´Â °Í;»ç¾ç
  • restriction endonuclease
    =RESTRICTION ENZYME
  • restriction enzyme
    Á¦ÇÑ È¿¼Ò(µÎÁÙ »ç½½ DNA¸¦ ƯÁ¤ ºÎÀ§¿¡¼­ Àý´ÜÇÏ´Â È¿¼Ò)
  • restriction site
    Á¦ÇÑ ºÎÀ§(Á¦ÇÑ È¿¼Ò°¡ Àý´ÜÇÏ´Â µÎ ÁÙ »ç½½ DNA»óÀÇ ºÎÀ§)
  • go to sleep
    ÀáÀÌ µé´Ù
  • sleep
    ÀÚ´Ù,¼ö¸é,¿µ¸é,Á×À½
  • to sleep
    ÀáÀÌ µé´Ù
  • REM sleep
    PARADOXICAL SLEEP
  • beauty sleep
    ÃÊÀú³á Àá
  • fox sleep
    ²ÒÀá
  • paradoxical sleep
    ¿ª¼³ ¼ö¸é
  • rapid eye movement sleep
    =REM sleep
  • sleep
    ÀÚ´Ù;¹¬´Ù;¼÷¹Ú ½ÃŰ´Ù;À̼º°ú ÀÚ´Ù;¸¶ºñµÇ´Ù;(ÆØÀ̰¡) ¼­´Ù;¼ö¸é(½Ã°£);Àáµê;¿µ¸é;µ¿¸é;¸¶ºñ;Á¤Áö(»óÅÂ);~ around ¾Æ¹«ÇÏ°í³ª ÀÚ´Ù;(¼ºÀûÀ¸·Î) ÇìÇÁ´Ù;~ away ÀáÀ» Àڸ纸³»´Ù;(µÎÅë µûÀ§¸¦)ÀáÀ» ÀÚ¼­ °íÄ¡´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á